NGMC Continuing Medical Education NGHS Media Services

Speaker: Olivia Peralta, MD
IM Resident, PGY-3

No Disclosures

Objectives:
-Pathophysiology of anaerobic and aerobic metabolism
- Prevalence of Lactic Acidosis and Prognostic Indications
-Types of Lactic Acidosis
-Role of Thiamine in the setting of persistent Lactic Acidosis
-Approach to and management of Lactic Acidosis

Speaker: Judy Mikhail, PhD, MBA, RN
Editor-in-Chief, Journal of Trauma Nursing
Program Manager, Michigan Trauma
Quality Improvement Program
University of Michigan

Disclosures: None

Objectives:
• Identify the outline of a scholarly article, including how to formulate a
compelling introduction, effectively discuss methods, present results, and
conclude with a powerful discussion that can stimulate further research.
• Employ strategies for clarity, conciseness and precision in one’s writing,
including identifying and rectifying common pitfalls such as passive voice,
excessive jargon or verbosity.
• Familiarize oneself with the submission and publication process, including
publication ethics and the stages of peer review.

Speaker:
Brian Schuler, MD
System Director, Clinical Cardiac Electrophysiology WellSpan Health, York, PA

Disclosures:
Speaker and Consultant: Canon Medical, USA
Speaker, Consultant, and Medical Advisory Board: Boston Scientific

Objectives:
•Demonstrate the utility of the CT-Angio Suite for EP/cath procedures.
•Review data strongly suggesting CT-guided LAAO is the gold standard of PDL prevention.
•Review data demonstrating CT-Angio Suite is a fee-for-service and value-based care champion.

Dr. Bedri Yusuf, Andrei Boyarshinov, Steve Kelly, Kassandra Lawson, Dr. Hellen Ransom, and Dr. Janeane Walker

Steve Kelly, Compliance
Kassandra Lawson, Associate Counsel, Legal Department
Hellen Ransom, PhD, Clinical Ethicist
Bedri Yusuf, MD, Chief Physician Executive
Janeane Walker, PhD, RN, Director Faculty Development and Educational Outcomes

Speaker: Ruben Ruiz Vega, MD
IM Resident, PGY-3

No Disclosures

Objectives:
• Understand the concept of ctDNA by defining what it is and learning its
relevance in cancer research and diagnostics.
• Grasp the clinical applications of ctDNA by discovering how ctDNA is utilized in
cancer diagnosis, prognosis, treatment monitoring and early detection, and the
potential impact on patient care.
• Identify the challenges and limitations of working with ctDNA, including issues
related to sensitivity and specificity.
• Explore ctDNA’s role in personalized medicine and its potential for other
medical applications.

Speaker: Aleksandros Mihilli, MD
PGY-3 IM Resident

No disclosures

Objectives:
•Understand how GLP-1RA function, and their use in diabetes and weight loss
•Compare the available GLP-1RA in terms of efficacy, and when to use which
•Look at future advancements in the field and what research is currently ongoing